ELMD Stock Overview
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$10.25|
|52 Week High||US$13.46|
|52 Week Low||US$8.75|
|1 Month Change||10.81%|
|3 Month Change||3.54%|
|1 Year Change||-4.30%|
|3 Year Change||62.70%|
|5 Year Change||42.56%|
|Change since IPO||157.54%|
Recent News & Updates
|ELMD||US Medical Equipment||US Market|
Return vs Industry: ELMD exceeded the US Medical Equipment industry which returned -31.2% over the past year.
Return vs Market: ELMD exceeded the US Market which returned -23.2% over the past year.
|ELMD Average Weekly Movement||6.3%|
|Medical Equipment Industry Average Movement||8.5%|
|Market Average Movement||6.9%|
|10% most volatile stocks in US Market||15.6%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: ELMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: ELMD's weekly volatility (6%) has been stable over the past year.
About the Company
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting.
Electromed Fundamentals Summary
|ELMD fundamental statistics|
Is ELMD overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ELMD income statement (TTM)|
|Cost of Revenue||US$10.22m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.27|
|Net Profit Margin||5.53%|
How did ELMD perform over the long term?See historical performance and comparison
Is ELMD undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 0/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ELMD?
Other financial metrics that can be useful for relative valuation.
|What is ELMD's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does ELMD's PE Ratio compare to its peers?
|ELMD PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
SRTS Sensus Healthcare
Price-To-Earnings vs Peers: ELMD is expensive based on its Price-To-Earnings Ratio (37.7x) compared to the peer average (11.2x).
Price to Earnings Ratio vs Industry
How does ELMD's PE Ratio compare vs other companies in the US Medical Equipment Industry?
Price-To-Earnings vs Industry: ELMD is expensive based on its Price-To-Earnings Ratio (37.7x) compared to the US Medical Equipment industry average (32.6x)
Price to Earnings Ratio vs Fair Ratio
What is ELMD's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||37.7x|
|Fair PE Ratio||20.1x|
Price-To-Earnings vs Fair Ratio: ELMD is expensive based on its Price-To-Earnings Ratio (37.7x) compared to the estimated Fair Price-To-Earnings Ratio (20.1x).
Share Price vs Fair Value
What is the Fair Price of ELMD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate ELMD's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate ELMD's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.
Discover undervalued companies
How is Electromed forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Future Growth Score3/6
Future Growth Score 3/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ELMD's forecast earnings growth (19.7% per year) is above the savings rate (1.9%).
Earnings vs Market: ELMD's earnings (19.7% per year) are forecast to grow faster than the US market (14.8% per year).
High Growth Earnings: ELMD's earnings are forecast to grow, but not significantly.
Revenue vs Market: ELMD's revenue (12.4% per year) is forecast to grow faster than the US market (7.7% per year).
High Growth Revenue: ELMD's revenue (12.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ELMD's Return on Equity is forecast to be high in 3 years time
Discover growth companies
How has Electromed performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ELMD has high quality earnings.
Growing Profit Margin: ELMD's current net profit margins (5.5%) are lower than last year (6.6%).
Past Earnings Growth Analysis
Earnings Trend: ELMD's earnings have grown by 6.5% per year over the past 5 years.
Accelerating Growth: ELMD's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ELMD had negative earnings growth (-2.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (-0.2%).
Return on Equity
High ROE: ELMD's Return on Equity (6.7%) is considered low.
Discover strong past performing companies
How is Electromed's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: ELMD's short term assets ($34.5M) exceed its short term liabilities ($7.2M).
Long Term Liabilities: ELMD's short term assets ($34.5M) exceed its long term liabilities ($41.0K).
Debt to Equity History and Analysis
Debt Level: ELMD is debt free.
Reducing Debt: ELMD has no debt compared to 5 years ago when its debt to equity ratio was 6%.
Debt Coverage: ELMD has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: ELMD has no debt, therefore coverage of interest payments is not a concern.
Discover healthy companies
What is Electromed current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
|Electromed Dividend Yield vs Market|
|Market Bottom 25% (US)||1.7%|
|Market Top 25% (US)||4.7%|
|Industry Average (Medical Equipment)||1.9%|
|Analyst forecast in 3 Years (Electromed)||n/a|
Notable Dividend: Unable to evaluate ELMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ELMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ELMD's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ELMD's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ELMD has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Kathleen Skarvan (66 yo)
Ms. Kathleen S. Skarvan has been the Chief Executive Officer of Electromed, Inc. since December 1, 2012 and its President since August 28, 2015. She is Independent Director of Citizens Community Bancorp, I...
CEO Compensation Analysis
|Kathleen Skarvan's Compensation vs Electromed Earnings|
|Date||Total Comp.||Salary||Company Earnings|
|Jun 30 2022||n/a||n/a|
|Mar 31 2022||n/a||n/a|
|Dec 31 2021||n/a||n/a|
|Sep 30 2021||n/a||n/a|
|Jun 30 2021||US$1m||US$410k|
|Mar 31 2021||n/a||n/a|
|Dec 31 2020||n/a||n/a|
|Sep 30 2020||n/a||n/a|
|Jun 30 2020||US$748k||US$410k|
|Mar 31 2020||n/a||n/a|
|Dec 31 2019||n/a||n/a|
|Sep 30 2019||n/a||n/a|
|Jun 30 2019||US$868k||US$397k|
|Mar 31 2019||n/a||n/a|
|Dec 31 2018||n/a||n/a|
|Sep 30 2018||n/a||n/a|
|Jun 30 2018||US$724k||US$345k|
|Mar 31 2018||n/a||n/a|
|Dec 31 2017||n/a||n/a|
|Sep 30 2017||n/a||n/a|
|Jun 30 2017||US$577k||US$285k|
|Mar 31 2017||n/a||n/a|
|Dec 31 2016||n/a||n/a|
|Sep 30 2016||n/a||n/a|
|Jun 30 2016||US$747k||US$238k|
Compensation vs Market: Kathleen's total compensation ($USD1.17M) is above average for companies of similar size in the US market ($USD774.31K).
Compensation vs Earnings: Kathleen's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Experienced Management: ELMD's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Experienced Board: ELMD's board of directors are considered experienced (5.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
|Owner Type||Number of Shares||Ownership Percentage|
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
Electromed, Inc.'s employee growth, exchange listings and data sources
- Name: Electromed, Inc.
- Ticker: ELMD
- Exchange: NYSEAM
- Founded: 1992
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: US$86.873m
- Shares outstanding: 8.48m
- Website: https://smartvest.com
Number of Employees
- Electromed, Inc.
- 500 Sixth Avenue NW
- New Prague
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ELMD||NYSEAM (NYSE MKT LLC)||Yes||Common Stock||US||USD||Aug 2010|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/10/01 00:00|
|End of Day Share Price||2022/09/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.